Document:

Exhibit

Exhibit 10.2

Amendment No.1 to Amended and Restated Joint Venture Agreement

This Amendment  No. 1 to the Amended and Restated Joint Venture Agreement (the "Amendment") is entered into as of the 15th day of October, 2010 between and among The Glad Products Company, a Delaware corporation, Glad Manufacturing Company, a Delaware corporation, Clorox Services Company, a Delaware corporation, The Clorox Sales Company, a Delaware corporation, Clorox International Company, a Delaware corporation (collectively  the "Clorox Parties"), and The Clorox Company, a Delaware corporation ("Clorox"), and The Procter & Gamble Company, an Ohio corporation ("P&G") and Procter & Gamble RHD Inc., an Ohio corporation ("P&G Sub" and collectively with P&G, the "P&G Parties") (each, a "Party" and collectively,  the "Parties"). Unless noted otherwise, capitalized terms used and not defined herein shall have the meaning set forth in the JV Agreement, as defined below.

WHEREAS, the Clorox Parties, Clorox, and the P&G Parties have entered into that certain Amended and Restated Joint Venture Agreement dated as of January 31, 2003 (the "JV Agreement"); and
WHEREAS, the Parties wish to amend the JV Agreement as set forth herein; NOW THEREFORE, the Parties hereby agree as follows:

1.     Section 1.1, definition of "Fair Market Value," will be amended by adding the following sentence at the end of the definition:

"In any determination of Fair Market Value, liabilities with respect to Defined Benefit Plans shall be accounted for and valued in accordance with Sections 7.5(d) and 7.5(f)."

		
	2. 
	Section 7.5(d) will be amended by deleting the first sentence and replacing it with the following:

"In the event of a Third-Party Sale by Clorox, Clorox will determine the actuarial liabilities with respect to the pensions of any defined benefit plans maintained by Clorox or any Affiliate which are subject to the funding requirements of Section 412 of the Code in which personnel engaged in the Glad Global Business at the time of the proposed sale are participating (the "Defined Benefit Plans"), as set forth in Section 7.5(f) below.  If a Defined Benefit Plan is not addressed in Section 7.5(f), then the actuarial liability will be determined based on the same actuarial assumptions that Clorox has used to fund such Defined Benefit Plan over time."

3.     The following shall be added to the JV Agreement as Section 7.5(f):

"(f)     Pension Liabilities. The Parties acknowledge and agree that certain liabilities with respect to that certain funded U.S. retirement and welfare plan referred to as the Clorox Pension Plan (the Clorox Pension Plan, along with any predecessor plan, referred to herein as the "Pension Plan") are reflected on the Glad Balance Sheet, and the Parties have agreed as follows with respect to the accounting and treatment of the assets and liabilities of such Pension Plan both on and off the Glad Balance Sheet, and the related impact on the value of the Parties' respective JV Interests as follows:
1.     The P&G Partners will have no obligation with respect to liabilities of the Pension Plan incurred prior to the Effective Date (the "Pre-Effective Date Pension Liabilities");
2.     The Parties agree that pension liabilities will be funded and accounted for in accordance with the "Global Glad Joint Venture (JV) Operating Practice and Procedures Hypothetical Pension Plan Calculations" attached hereto as Exhibit A (the "Plan Practice and Procedures"), which creates a Hypothetical Pension Fund ("the Fund") for purpose of accounting for and funding pension liabilities. Capitalized terms used in this Section 7.5(f) and not otherwise defined herein will have the meanings set forth in the Plan Practice and Procedures.
3.     This Section 7.5(f)  will not apply to any international  welfare and retirement plans, or to unfunded welfare and retirement plans, including, but not limited to, LTD/STD FAS 112; Post Retirement Medical; Supplemental  Executive Retirement Plan; Clorox Non-Qualified Deferred Compensation; First Brands Non-Qualified Deferred Compensation.

5.     Section 11.3 shall be amended by deleting the address for copies of notices to the P&G Partners and replacing it with the following:

"The Procter & Gamble Company
One P&G Plaza
Cincinnati, Ohio 45202
Attention: Joseph A. Stegbauer, Director, Transactions Group
Telecopy: (513) 983-2611
Telephone: (513) 983-2810
E-mail: stegbauer.ja@pg.com"

6.     Exhibit H, paragraph 14 shall be amended by deleting the paragraph in its entirety and replacing it with the following:

"To the extent either Clorox or P&G adopts the accounting position of expensing its stock options or other equity compensation required to be expensed under FAS rules, it will be able to attribute such stock option or equity compensation expense with respect to the personnel engaged in the Glad business to the Glad Global Business to the extent such expense is a direct cost.

7.     Governing Law.  This Amendment will be governed by the laws of the State of New York.

8.     No Other Modifications.  Except as expressly modified herein, all provisions of the JV Agreement shall remain in full force and effect on the terms and conditions set forth therein.

9.     Counterparts.  This Amendment may be executed in one or more counterparts, by facsimile or original signature, each of which shall be deemed an original and all of which, taken together, shall constitute one and the same instrument.

[remainder of page intentionally left blank; signature pages to follow]

IN WITNESS WHEREOF, the Parties have executed this Amendment, effective as of the date first set forth above.

	
	
	THE CLOROX COMPANY
   
By:   /s/ Larry Peiros      
Name:  Larry Peiros         
Title:  Executive Vice President      

	THE GLAD PRODUCTS COMPANY
   
By:   /s/ Larry Peiros      
Name:   Larry Peiros         
Title:   Vice President            

	GLAD MANUFACTURING COMPANY   
By:   /s/ Larry Peiros      
Name:   Larry Peiros         
Title:   Vice President            

	CLOROX SERVICES COMPANY   
By:   /s/ Larry Peiros      
Name:   Larry Peiros         
Title:   Vice President            

	THE CLOROX SALES COMPANY   
By:   /s/ Larry Peiros      
Name:   Larry Peiros         
Title:   Vice President            

	CLOROX INTERNATIONAL COMPANY   
By:   /s/ Larry Peiros      
Name:   Larry Peiros         
Title:   Vice President            

	
	
	THE PROCTER & GAMBLE COMPANY   
By:   /s/ Jeffrey D. Weedman      
Name:   Jeffrey D. Weedman      
Title:   Vice President, Global Business Development

	PROCTER & GAMBLE RHD, INC.   
By:   /s/ Jeffrey D. Weedman      
Name:   Jeffrey D. Weedman      
Title:   Vice President, Global Business DevelopmentExhibit
4.1

 

Form
of Warrant

 

Form
of Underwriter’s Warrant Agreement

 

THE
REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES BY HIS, HER OR ITS ACCEPTANCE HEREOF, THAT SUCH HOLDER WILL NOT FOR A PERIOD
OF ONE HUNDRED EIGHTY (180) DAYS FOLLOWING THE EFFECTIVE DATE (AS DEFINED BELOW) OF THE REGISTRATION STATEMENT: (A) SELL, TRANSFER,
ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT TO ANYONE OTHER THAN OFFICERS OR PARTNERS OF BOUSTEAD, EACH OF WHOM SHALL
HAVE AGREED TO THE RESTRICTIONS CONTAINED HEREIN, IN ACCORDANCE WITH FINRA CONDUCT RULE 5110(G)(1), OR (B) CAUSE THIS PURCHASE
WARRANT OR THE SECURITIES ISSUABLE HEREUNDER TO BE THE SUBJECT OF ANY HEDGING, SHORT SALE, DERIVATIVE, PUT OR CALL TRANSACTION
THAT WOULD RESULT IN THE EFFECTIVE ECONOMIC DISPOSITION OF THIS PURCHASE WARRANT OR THE SECURITIES HEREUNDER, EXCEPT AS PROVIDED
FOR IN FINRA RULE 5110(G)(2).

 

THIS
PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [●], 20[__] [DATE THAT IS THE EFFECTIVE DATE OF THE OFFERING]. VOID AFTER 5:00
P.M., EASTERN TIME, [●], 20[__] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING].

 

COMMON
STOCK PURCHASE WARRANT

 

For
the Purchase of [●] Shares of Common Stock

 

of

AERKOMM INC.

 

1.           Purchase
Warrant. THIS CERTIFIES THAT, pursuant to that certain Underwriting Agreement by and between Aerkomm Inc., a Nevada corporation
(the “Company”) and Boustead Securities, LLC (“Boustead”), dated [●], 2018 (the “Underwriting
Agreement”), Boustead (in such capacity with its permitted successors or assigns, the “Holder”),
as registered owner of this Purchase Warrant, is entitled, at any time or from time to time from [●], 20[__] (the “Exercise
Date”) [THE DATE THAT IS THE EFFECTIVE DATE OF THE REGISTRATION STATEMENT], and at or before 5:00 p.m., Eastern time,
[●], 20[ ] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the “Expiration Date”),
but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of Common Stock of the
Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 hereof.
If the Expiration Date is a day on which banking institutions are authorized by law or executive order to close, then this Purchase
Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period
commencing on the date hereof and ending on the Expiration Date, the Company agrees not to take any action that would terminate
this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] per Share (100% of the price of the Shares
sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 5 hereof,
the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon
such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise
price or the adjusted exercise price, depending on the context. Any term not defined herein shall have the meaning ascribed thereto
in the Underwriting Agreement.

 

2.           Exercise.

 

2.1          Exercise
Form. In order to exercise this Purchase Warrant, the exercise form attached hereto as Exhibit A (the “Exercise
Form”) must be duly executed and completed and delivered to the Company, together with this Purchase Warrant and payment
of the Exercise Price for the Shares being purchased payable in cash by wire transfer of immediately available funds to an account
designated by the Company or by certified check or official bank check to the order of the Company. If the subscription rights
represented hereby shall not be exercised at or before 5:00 p.m., Eastern time, on the Expiration Date, this Purchase Warrant
shall become and be void without further force or effect, and all rights represented hereby shall cease and expire.

 

    	 		 

     

    

 

2.2          Cashless
Exercise. In lieu of exercising this Purchase Warrant by payment of cash or check payable to the order of the Company pursuant
to Section 2.1 above, Holder may elect to receive the number of Shares equal to the value of this Purchase Warrant
(or the portion thereof being exercised), by surrender of this Purchase Warrant to the Company, together with the Exercise Form,
in which event the Company shall issue to Holder, Shares in accordance with the following formula:

 

	 	X	=	Y(A
    – B)	 
	 	 	 	A	 

 

		Where,	X   =    The
    number of Shares to be issued to Holder;

Y   =    The
number of Shares for which the Purchase Warrant is being exercised;

A   =    The
fair market value of one Share; and

B   =    The
Exercise Price.

 

For
purposes of this Section 2.2, the fair market value of a Share is defined as follows:

 

(i)          if
the Company’s Common Stock is traded on a securities exchange, the value shall be deemed to be the closing price on such
exchange on the trading day immediately prior to the Exercise Form being submitted in connection with the exercise of this Purchase
Warrant; or

 

(ii)         if
the Company’s Common Stock is actively traded over-the-counter, the value shall be deemed to be the closing bid price on
the trading day immediately prior to the Exercise Form being submitted in connection with the exercise of the Purchase Warrant;
if there is no active public market, the value shall be the fair market value thereof, as determined in good faith by the Company’s
Board of Directors.

  

2.3          Lockup.
The holder of this Purchase Warrant represents that it (or permitted assignees under FINRA Rule 5110(g)(1)) will not sell, transfer,
assign, pledge, or hypothecate this Purchase Warrant or the securities underlying the Purchase Warrant, nor will it engage in
any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants
or the underlying securities for a period of 180 days from the effective date of the offering, except as provided for in FINRA
Rule 5110(g)(2).

 

3.           Transfer.

 

3.1          General
Restrictions. The registered Holder of this Purchase Warrant agrees by his, her or its acceptance hereof, that such Holder
will not for a period of one hundred eighty (180) days following the Effective Date of the Registration Statement: (a) sell, transfer,
assign, pledge or hypothecate this Purchase Warrant to anyone other than: (i) Boustead or an underwriter or a selected dealer
participating in the offering (the “Offering”) contemplated by the Underwriting Agreement, or (ii) officers
or partners of Boustead, each of whom shall have agreed to the restrictions contained herein, in accordance with FINRA Conduct
Rule 5110(g)(1), or (b) cause this Purchase Warrant or the securities issuable hereunder to be the subject of any hedging,
short sale, derivative, put or call transaction that would result in the effective economic disposition of this Purchase Warrant
or the securities hereunder, except as provided for in FINRA Rule 5110(g)(2). On and after that date that is one hundred eighty
(180) days after the Effective Date of the Registration Statement, transfers to others may be made subject to compliance with
or exemptions from applicable securities laws. In order to make any permitted assignment, the Holder must deliver to the Company
the assignment form attached hereto as Exhibit B duly executed and completed, together with this Purchase Warrant
and payment of all transfer taxes, if any, payable in connection therewith. The Company shall within five (5) Business Days transfer
this Purchase Warrant on the books of the Company and shall execute and deliver a new Purchase Warrant or Purchase Warrants of
like tenor to the appropriate assignee(s) expressly evidencing the right to purchase the aggregate number of Shares purchasable
hereunder or such portion of such number as shall be contemplated by any such assignment.

 

3.2          Restrictions
Imposed by the Act. The securities evidenced by this Purchase Warrant shall not be transferred unless and until: (i) the Company
has received the opinion of counsel for the Holder that the securities may be transferred pursuant to an exemption from registration
under the Act and applicable state securities laws, the availability of which is established to the reasonable satisfaction of
the Company, (ii) a Registration Statement relating to the offer and sale of such securities that includes a current prospectus
has been filed and declared effective by the Securities and Exchange Commission (the “Commission”) and compliance
with applicable state securities law has been established.

 

    	 	2	 

     

    

 

4.           New
Purchase Warrants to be Issued.

 

4.1          Partial
Exercise or Transfer. Subject to the restrictions in Section 3 hereof, this Purchase Warrant may be exercised
or assigned in whole or in part. In the event of the exercise or assignment hereof in part only, upon surrender of this Purchase
Warrant for cancellation, together with the duly executed exercise or assignment form and funds sufficient to pay any Exercise
Price and/or transfer tax if exercised pursuant to Section 2.1 hereof, the Company shall cause to be delivered
to the Holder without charge a new Purchase Warrant of like tenor to this Purchase Warrant in the name of the Holder evidencing
the right of the Holder to purchase the number of Shares purchasable hereunder as to which this Purchase Warrant has not been
exercised or assigned.

 

4.2          Lost
Certificate. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of this
Purchase Warrant and of reasonably satisfactory indemnification or the posting of a bond, the Company shall execute and deliver
a new Purchase Warrant of like tenor and date. Any such new Purchase Warrant executed and delivered as a result of such loss,
theft, mutilation or destruction shall constitute a substitute contractual obligation on the part of the Company.

 

5.           Adjustments.

 

5.1          Adjustments
to Exercise Price and Number of Shares. The Exercise Price and the number of Shares underlying this Purchase Warrant shall
be subject to adjustment from time to time as hereinafter set forth:

 

5.1.1       Share
Dividends; Split Ups. If, after the date hereof, and subject to the provisions of Section 5.3 below, the
number of outstanding Shares is increased by a stock dividend payable in Shares or by a split up of Shares or other similar event,
then, on the effective day thereof, the number of Shares purchasable hereunder shall be increased in proportion to such increase
in outstanding shares, and the Exercise Price shall be proportionately decreased.

 

5.1.2       Aggregation
of Shares. If, after the date hereof, and subject to the provisions of Section 5.3 below, the number of outstanding
Shares is decreased by a consolidation, combination or reclassification of Shares or other similar event, then, on the effective
date thereof, the number of Shares purchasable hereunder shall be decreased in proportion to such decrease in outstanding shares,
and the Exercise Price shall be proportionately increased.

 

5.1.3       Replacement
of Shares upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding Shares other than
a change covered by Section 5.1.1 or Section 5.1.2 hereof or that solely affects the par
value of such Shares, or in the case of any share reconstruction or amalgamation or consolidation of the Company with or into
another corporation (other than a consolidation or share reconstruction or amalgamation in which the Company is the continuing
corporation and that does not result in any reclassification or reorganization of the outstanding Shares), or in the case of any
sale or conveyance to another corporation or entity of the property of the Company as an entirety or substantially as an entirety
in connection with which the Company is dissolved, the Holder of this Purchase Warrant shall have the right thereafter (until
the expiration of the right of exercise of this Purchase Warrant) to receive upon the exercise hereof, for the same aggregate
Exercise Price payable hereunder immediately prior to such event, the kind and amount of shares of stock or other securities or
property (including cash) receivable upon such reclassification, reorganization, share reconstruction or amalgamation, or consolidation,
or upon a dissolution following any such sale or transfer, by a Holder of the number of Shares of the Company obtainable upon
exercise of this Purchase Warrant immediately prior to such event; and if any reclassification also results in a change in Shares
covered by Section 5.1.1 or Section 5.1.2, then such adjustment shall be made pursuant to Section
5.1.1, Section 5.1.2 and this Section 5.1.3. The provisions of this Section 5.1.3 shall
similarly apply to successive reclassifications, reorganizations, share reconstructions or amalgamations, or consolidations, sales
or other transfers.

   

5.1.4       Changes
in Form of Purchase Warrant. This form of Purchase Warrant need not be changed because of any change pursuant to this Section
5.1, and Purchase Warrants issued after such change may state the same Exercise Price and the same number of Shares as are
stated in the Purchase Warrants initially issued pursuant to this Agreement. The acceptance by any Holder of the issuance of new
Purchase Warrants reflecting a required or permissive change shall not be deemed to waive any rights to an adjustment occurring
after the date hereof or the computation thereof.

 

    	 	3	 

     

    

 

5.2          Substitute
Purchase Warrant. In case of any consolidation of the Company with, or share reconstruction or amalgamation of the Company
with or into, another corporation (other than a consolidation or share reconstruction or amalgamation which does not result in
any reclassification or change of the outstanding Shares), the corporation formed by such consolidation or share reconstruction
or amalgamation shall execute and deliver to the Holder a supplemental Purchase Warrant providing that the holder of each Purchase
Warrant then outstanding or to be outstanding shall have the right thereafter (until the stated expiration of such Purchase Warrant)
to receive, upon exercise of such Purchase Warrant, the kind and amount of shares of stock and other securities and property receivable
upon such consolidation or share reconstruction or amalgamation, by a holder of the number of Shares of the Company for which
such Purchase Warrant might have been exercised immediately prior to such consolidation, share reconstruction or amalgamation,
sale or transfer. Such supplemental Purchase Warrant shall provide for adjustments which shall be identical to the adjustments
provided for in this Section 5. The above provision of this Section 5 shall similarly apply to successive
consolidations or share reconstructions or amalgamations.

 

5.3          Elimination
of Fractional Interests. The Company shall not be required to issue certificates representing fractions of Shares upon the
exercise of the Purchase Warrant, nor shall it be required to issue scrip or pay cash in lieu of any fractional interests, it
being the intent of the parties that all fractional interests shall be eliminated by rounding any fraction up or down, as the
case may be, to the nearest whole number of Shares or other securities, properties or rights.

 

6.           Reservation
and Listing. The Company shall at all times reserve and keep available out of its authorized Shares, solely for the purpose
of issuance upon exercise of this Purchase Warrant, such number of Shares or other securities, properties or rights as shall be
issuable upon the exercise thereof. The Company covenants and agrees that, upon exercise of this Purchase Warrant and payment
of the Exercise Price therefor, in accordance with the terms hereby, all Shares and other securities issuable upon such exercise
shall be duly and validly issued, fully paid and non-assessable and not subject to preemptive rights of any shareholder. The Company
further covenants and agrees that upon exercise of this Purchase Warrant and payment of the exercise price therefor, all Shares
and other securities issuable upon such exercise shall be duly and validly issued, fully paid and non-assessable and not subject
to preemptive rights of any shareholder. As long as this Purchase Warrant shall be outstanding, the Company shall use its commercially
reasonable efforts to cause all Shares issuable upon exercise of this Purchase Warrant to be listed (subject to official notice
of issuance) on all national securities exchanges (or, if applicable, on the OTC Bulletin Board or any successor trading market)
on which the Shares issued to the public in the Offering may then be listed and/or quoted.

 

7.           Certain
Notice Requirements.

 

7.1          Holder’s
Right to Receive Notice. Nothing herein shall be construed as conferring upon the Holders the right to vote or consent or
to receive notice as a shareholder for the election of directors or any other matter, or as having any rights whatsoever as a
shareholder of the Company. If, however, at any time prior to the expiration of the Purchase Warrants and their exercise, any
of the events described in Section 7.2 shall occur, then, in one or more of said events, the Company shall give
written notice of such event at least fifteen days prior to the date fixed as a record date or the date of closing the transfer
books (the “Notice Date”) for the determination of the shareholders entitled to such dividend, distribution,
conversion or exchange of securities or subscription rights, or entitled to vote on such proposed dissolution, liquidation, winding
up or sale. Such notice shall specify such record date or the date of the closing of the transfer books, as the case may be. Notwithstanding
the foregoing, the Company shall deliver to each Holder a copy of each notice given to the other shareholders of the Company at
the same time and in the same manner that such notice is given to the shareholders.

 

7.2          Events
Requiring Notice. The Company shall be required to give the notice described in this Section 7 upon one or
more of the following events: (i) if the Company shall take a record of the holders of its Shares for the purpose of entitling
them to receive a dividend or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise
than out of retained earnings, as indicated by the accounting treatment of such dividend or distribution on the books of the Company,
(ii) the Company shall offer to all the holders of its Shares any additional shares of capital stock of the Company or securities
convertible into or exchangeable for shares of capital stock of the Company, or any option, right or warrant to subscribe therefor,
or (iii) a dissolution, liquidation or winding up of the Company (other than in connection with a consolidation or share reconstruction
or amalgamation) or a sale of all or substantially all of its property, assets and business shall be proposed.

 

    	 	4	 

     

    

 

7.3          Notice
of Change in Exercise Price. The Company shall, promptly after an event requiring a change in the Exercise Price pursuant
to Section 5 hereof, send notice to the Holders of such event and change (“Price Notice”).
The Price Notice shall describe the event causing the change and the method of calculating same and shall be certified as being
true and accurate by the Company’s Chief Financial Officer.

 

7.4          Transmittal
of Notices. All notices, requests, consents and other communications under this Purchase Warrant shall be in writing and shall
be deemed to have been duly made (1) when hand delivered, (2) when mailed by express mail or private courier service or (3)
when the event requiring notice is disclosed in all material respects and filed in a current report on Form 8-K or in a definitive
proxy statement on Schedule 14A prior to the Notice Date: (i) if to the registered Holder of the Purchase Warrant, to the address
of such Holder as shown on the books of the Company, or (ii) if to the Company, to following address or to such other address
as the Company may designate by notice to the Holders:

  

If
to the Holder:

 

Boustead
Securities, LLC

898
N. Sepulveda Blvd., Suite 475,

El
Segundo, CA 90245

Attention:
Keith Moore, CEO

Fax:
(815) 301-8099

 

with
a copy (which shall not constitute notice) to:

 

Mei
& Mark LLP

818 18th Street NW, Suite 410

Washington, DC 20006

Fax: (888) 706-1173

Attn:
Fang Liu, Esq.

 

If
to the Company:

 

Aerkomm
Inc.

923
Incline Way #39

Incline
Village, NV 89451

Attention:

Fax:

 

with
a copy (which shall not constitute notice) to:

 

BEVILACQUA
PLLC

1050
Connecticut Avenue NW Suite 500

Washington,
DC 20036

Fax:

Attn:
Louis A. Bevilacqua, Esq.

 

8.           Miscellaneous.

 

8.1          Amendments.
The Company and Boustead may from time to time supplement or amend this Purchase Warrant without the approval of any of the Holders
in order to cure any ambiguity, to correct or supplement any provision contained herein that may be defective or inconsistent
with any other provisions herein, or to make any other provisions in regard to matters or questions arising hereunder that the
Company and Boustead may deem necessary or desirable and that the Company and Boustead deem shall not adversely affect the interest
of the Holders. All other modifications or amendments shall require the written consent of and be signed by the party against
whom enforcement of the modification or amendment is sought.

 

    	 	5	 

     

    

 

8.2          Headings.
The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the
meaning or interpretation of any of the terms or provisions of this Purchase Warrant.

   

8.3          Entire
Agreement. This Purchase Warrant (together with the other agreements and documents being delivered pursuant to or in connection
with this Purchase Warrant) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof,
and supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.

 

8.4          Binding
Effect. This Purchase Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the Company and
their permitted assignees and respective successors and no other person shall have or be construed to have any legal or equitable
right, remedy or claim under or in respect of or by virtue of this Purchase Warrant or any provisions herein contained.

 

8.5          Governing
Law; Submission to Jurisdiction. This Purchase Warrant shall be governed by and construed and enforced in accordance with
the laws of the State of California, without giving effect to conflict of laws principles thereof. The Company hereby agrees that
any action, proceeding or claim against it arising out of, or relating in any way to this Purchase Warrant shall be brought and
enforced in the California Supreme Court, Los Angeles County , or in the United States District Court for the Central District
of California, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives
any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Any process or summons to be
served upon the Company may be served by transmitting a copy thereof by registered or certified mail, return receipt requested,
postage prepaid, addressed to it at the address set forth in Section 8 hereof. Such mailing shall be deemed personal
service and shall be legal and binding upon the Company in any action, proceeding or claim. The Company and the Holder agree that
the prevailing party(ies) in any such action shall be entitled to recover from the other party(ies) all of its reasonable attorneys’
fees and expenses relating to such action or proceeding and/or incurred in connection with the preparation therefor.

 

8.6          Waiver,
etc. The failure of the Company or the Holder to at any time enforce any of the provisions of this Purchase Warrant shall
not be deemed or construed to be a waiver of any such provision, nor to in any way affect the validity of this Purchase Warrant
or any provision hereof or the right of the Company or any Holder to thereafter enforce each and every provision of this Purchase
Warrant. No waiver of any breach, non-compliance or non-fulfillment of any of the provisions of this Purchase Warrant shall be
effective unless set forth in a written instrument executed by the party or parties against whom or which enforcement of such
waiver is sought; and no waiver of any such breach, non-compliance or non-fulfillment shall be construed or deemed to be a waiver
of any other or subsequent breach, non-compliance or non-fulfillment.

 

8.7          Exchange
Agreement. As a condition of the Holder’s receipt and acceptance of this Purchase Warrant, Holder agrees that, at any
time prior to the complete exercise of this Purchase Warrant by Holder, if the Company and Boustead enter into an agreement (“Exchange
Agreement”) pursuant to which they agree that all outstanding Purchase Warrants will be exchanged for securities or
cash or a combination of both, then Holder shall agree to such exchange and become a party to the Exchange Agreement.

 

8.8          Execution
in Counterparts. This Purchase Warrant may be executed in one or more counterparts, and by the different parties hereto in
separate counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and
the same agreement, and shall become effective when one or more counterparts has been signed by each of the parties hereto and
delivered to each of the other parties hereto. Such counterparts may be delivered by facsimile transmission or other electronic
transmission.

 

[Remainder
of page intentionally left blank.]

 

    	 	6	 

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Purchase Warrant to be signed by its duly authorized officer as of the ____ day
of _______, 2018.

 

	AERKOMM
    INC.	 
	 	 	 
	By:	      	 
	 	Name:	 
	 	Title:	 

 

     

     

    

 

EXHIBIT
A

 

Form
to be used to exercise Purchase Warrant:

 

Date:
__________, 20___

 

The
undersigned hereby elects irrevocably to exercise the Purchase Warrant for ______ Shares of Aerkomm Inc., a Nevada corporation
(the “Company”) and hereby makes payment of $____ (at the rate of $____ per Share) in payment of the Exercise
Price pursuant thereto. Please issue the Shares as to which this Purchase Warrant is exercised in accordance with the instructions
given below and, if applicable, a new Purchase Warrant representing the number of Shares for which this Purchase Warrant has not
been exercised.

 

or

 

The
undersigned hereby elects irrevocably to convert its right to purchase ___ Shares under the Purchase Warrant for ______ Shares,
as determined in accordance with the following formula:

 

	 	X	=	Y(A-B)	 
	 	 	 	A	 

 

		Where,	X   =   The
    number of Shares to be issued to Holder;

Y   =   The
number of Shares for which the Purchase Warrant is being exercised;

A   =   The
fair market value of one Share which is equal to $_____; and

B   =   The
Exercise Price which is equal to $______ per share

 

The
undersigned agrees and acknowledges that the calculation set forth above is subject to confirmation by the Company and any disagreement
with respect to the calculation shall be resolved by the Company in its sole discretion.

 

Please
issue the Shares as to which this Purchase Warrant is exercised in accordance with the instructions given below and, if applicable,
a new Purchase Warrant representing the number of Shares for which this Purchase Warrant has not been exercised.

 

Signature

 

Signature
Guaranteed

 

     

     

    

 

INSTRUCTIONS
FOR REGISTRATION OF SECURITIES

 

Name:

 

(Print
in Block Letters)

 

Address:

 

NOTICE:
The signature to this form must correspond with the name as written upon the face of the Purchase Warrant without alteration or
enlargement or any change whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or by
a firm having membership on a registered national securities exchange.

 

     

     

    

 

EXHIBIT
B

 

Form
to be used to assign Purchase Warrant:

 

(To
be executed by the registered Holder to effect a transfer of the within Purchase Warrant):

 

FOR
VALUE RECEIVED,                                                                       does
hereby sell, assign and transfer unto the right to purchase shares of Aerkomm Inc., a Nevada corporation (the “Company”),
evidenced by the Purchase Warrant and does hereby authorize the Company to transfer such right on the books of the Company.

 

Dated:  ____________,
20__

 

Signature

 

NOTICE:
The signature to this form must correspond with the name as written upon the face of the within Purchase Warrant without alteration
or enlargement or any change whatsoever.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}]]